Tesla’s Q2 Earnings Isn’t About Car Deliveries — It’s About Whether Optimus and Robotaxi Justify the Capex Burn

Posted on by

(SeaPRwire) –   By: Ethan Gallagher

Everyone’s asking if Tesla stock is a buy ahead of Q2 earnings. They’re asking the wrong question. The 480,126 Q2 deliveries already beat estimates, and the stock still sits 15% down year-to-date. No one’s trading Tesla on car sales anymore. I sat down with a hedge fund contact for coffee last Tuesday. He dumped 40% of his TSLA position in June. His reason? He couldn’t pin a valuation on a company doubling capex with no clear line of sight to non-auto revenue. That’s the real stakes for July 22’s earnings call. It’s not about EPS beats or margin tweaks. It’s about whether Tesla can prove its AI and robotics spending isn’t just a vanity project dragging down free cash flow. Wall Street’s consensus Hold rating and 6.5% implied upside? That’s just analysts sitting on the fence until they get proof.

The official earnings headline numbers tell a straightforward story. Wall Street expects adjusted EPS of $0.52 to $0.54, with revenue around $26.4 billion. That’s roughly 16% growth year-over-year. Tesla already reported 480,126 vehicles delivered in Q2, against 451,758 units produced. The delivery number beat consensus estimates. It did nothing to move the stock. Automotive gross margin is the most watched line item on the income statement. Consensus pegs it just above 18%, excluding regulatory credits. Wells Fargo’s Colin Langan is far more bearish. He forecasts 16.8%, well below Q1’s 19.2% margin. He points to lower vehicle pricing and the end of one-time benefits from earlier this year. Langan holds a Sell rating with a $130 price target. He cites weak EV demand, unclear new model launch timelines, and regulatory risks around autonomous driving. The subtext here is harder to miss. The market has already stopped rewarding Tesla for delivery beats. The margin debate isn’t just about quarterly pricing moves. It’s about whether Tesla’s core auto business can support the company’s massive spending on side projects. Langan’s $130 target isn’t a random lowball. It’s a valuation that treats Tesla like a traditional carmaker, not a high-growth tech firm. The 15% year-to-date drop is the market slowly stripping out the tech premium that made Tesla the most valuable automaker in the world.

The real action on the earnings call will be around non-auto updates. UBS’s Joseph Spak reiterated a Hold rating but lifted his price target to $442. He thinks Tesla could beat Q2 EPS estimates by as much as 37%. He also sees a better chance that 2026 full-year vehicle deliveries won’t drop year-over-year. That could push other analysts to raise their own estimates. Morgan Stanley’s Andrew Percoco kept his Hold rating and nudged his target up to $417. He expects solid auto and energy delivery numbers. He says the bigger question is whether Tesla’s accelerating AI investment cycle is worth the cost. Capex is more than doubling, and free cash flow is turning negative. Investors want proof the spending is building a real competitive advantage. Bank of America’s Alexander Perry is focused on robotaxi rollout progress. Tesla now operates in five markets, after launching in Miami on July 3. Four more markets are in preparation. Safety data through mid-June shows 22 incidents since launch, with no serious injuries or fatalities. Perry says that number is helping ease skepticism around Tesla’s vision-only autonomous driving approach. Optimus is the other big wildcard. Tesla targets initial humanoid robot production at its Fremont facility in late July or August. A Gen 3 Optimus reveal could happen around the same time. Supplier guidance points to roughly 1,000 units per week by September. That could scale to 2,000 to 2,500 units per week by year-end. Morgan Stanley expects Elon Musk to address Optimus production ramp, final design, and early use cases on the call. The subtext here is that none of these projects have proven commercial viability yet. The robotaxi safety numbers lack context. We don’t have total miles driven or intervention rates to compare to human drivers. The vision-only approach still faces deep regulatory scrutiny in most major markets. Optimus production targets sound aggressive, but those units are likely early prototypes, not revenue-generating products. The 16 Hold, 10 Buy, 3 Sell consensus rating reflects this uncertainty. The average $405.42 price target implies just 6.5% upside from current levels. Options markets are pricing in a 7% swing in either direction after earnings. That’s the market betting on either a breakthrough product update, or another round of vague promises that fail to justify the spending.

The supply chain for humanoid robots is no longer a niche, experimental space. Tesla’s Optimus production targets are already pulling tier-1 component suppliers off the fence. Firms that once focused solely on auto or consumer electronics parts are now retooling lines for robotic actuators, precision sensors, and compact battery packs. Tesla doesn’t need to ship a single commercial Optimus unit this year to shift the market. Its public ramp targets are forcing every other robotics player to lock in their own supply agreements, driving down component costs across the entire humanoid robot sector.

Author bio: Ethan Gallagher, a Silicon Valley hardware architect with 15 years of experience in AI infrastructure and robotics supply chain strategy.